Trevi Therapeutics, Inc. TRVI Options canceled (in dollars per share)
Options canceled (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s options canceled (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s options canceled (in dollars per share)?
- Trevi Therapeutics, Inc. (TRVI) reported options canceled (in dollars per share) of $6.74 in Q1 2026.
- How has Trevi Therapeutics, Inc.'s options canceled (in dollars per share) changed year-over-year?
- Trevi Therapeutics, Inc.'s options canceled (in dollars per share) increased by 183.2% year-over-year, from $2.38 to $6.74.
- What does options canceled (in dollars per share) mean?
- The weighted-average exercise price of stock options that were canceled during the period. This metric helps investors understand the potential impact of underwater or forfeited options on the company's overall equity compensation structure.